chr3-142562770-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001184.4(ATR):​c.632T>C​(p.Met211Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.577 in 1,609,006 control chromosomes in the GnomAD database, including 272,275 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M211I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.63 ( 30706 hom., cov: 32)
Exomes 𝑓: 0.57 ( 241569 hom. )

Consequence

ATR
NM_001184.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.48

Publications

92 publications found
Variant links:
Genes affected
ATR (HGNC:882): (ATR serine/threonine kinase) The protein encoded by this gene is a serine/threonine kinase and DNA damage sensor, activating cell cycle checkpoint signaling upon DNA stress. The encoded protein can phosphorylate and activate several proteins involved in the inhibition of DNA replication and mitosis, and can promote DNA repair, recombination, and apoptosis. This protein is also important for fragile site stability and centrosome duplication. Defects in this gene are a cause of Seckel syndrome 1. [provided by RefSeq, Aug 2017]
ATR Gene-Disease associations (from GenCC):
  • Seckel syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Illumina, G2P, Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome
    Inheritance: Unknown, AD Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • Seckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • familial prostate carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.809924E-7).
BP6
Variant 3-142562770-A-G is Benign according to our data. Variant chr3-142562770-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93668.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.784 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATRNM_001184.4 linkc.632T>C p.Met211Thr missense_variant Exon 4 of 47 ENST00000350721.9 NP_001175.2 Q13535-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATRENST00000350721.9 linkc.632T>C p.Met211Thr missense_variant Exon 4 of 47 1 NM_001184.4 ENSP00000343741.4 Q13535-1

Frequencies

GnomAD3 genomes
AF:
0.625
AC:
95022
AN:
151920
Hom.:
30655
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.790
Gnomad AMI
AF:
0.679
Gnomad AMR
AF:
0.534
Gnomad ASJ
AF:
0.560
Gnomad EAS
AF:
0.464
Gnomad SAS
AF:
0.443
Gnomad FIN
AF:
0.539
Gnomad MID
AF:
0.614
Gnomad NFE
AF:
0.587
Gnomad OTH
AF:
0.621
GnomAD2 exomes
AF:
0.548
AC:
135126
AN:
246404
AF XY:
0.544
show subpopulations
Gnomad AFR exome
AF:
0.797
Gnomad AMR exome
AF:
0.456
Gnomad ASJ exome
AF:
0.567
Gnomad EAS exome
AF:
0.470
Gnomad FIN exome
AF:
0.552
Gnomad NFE exome
AF:
0.580
Gnomad OTH exome
AF:
0.555
GnomAD4 exome
AF:
0.572
AC:
833938
AN:
1456968
Hom.:
241569
Cov.:
55
AF XY:
0.568
AC XY:
411764
AN XY:
724462
show subpopulations
African (AFR)
AF:
0.802
AC:
26595
AN:
33170
American (AMR)
AF:
0.464
AC:
20207
AN:
43556
Ashkenazi Jewish (ASJ)
AF:
0.562
AC:
14554
AN:
25916
East Asian (EAS)
AF:
0.444
AC:
17630
AN:
39670
South Asian (SAS)
AF:
0.435
AC:
36925
AN:
84936
European-Finnish (FIN)
AF:
0.548
AC:
29225
AN:
53328
Middle Eastern (MID)
AF:
0.564
AC:
3237
AN:
5742
European-Non Finnish (NFE)
AF:
0.586
AC:
650978
AN:
1110492
Other (OTH)
AF:
0.575
AC:
34587
AN:
60158
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
20930
41859
62789
83718
104648
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17858
35716
53574
71432
89290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.626
AC:
95120
AN:
152038
Hom.:
30706
Cov.:
32
AF XY:
0.618
AC XY:
45903
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.791
AC:
32790
AN:
41470
American (AMR)
AF:
0.534
AC:
8152
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.560
AC:
1943
AN:
3468
East Asian (EAS)
AF:
0.464
AC:
2397
AN:
5162
South Asian (SAS)
AF:
0.443
AC:
2138
AN:
4826
European-Finnish (FIN)
AF:
0.539
AC:
5692
AN:
10566
Middle Eastern (MID)
AF:
0.605
AC:
178
AN:
294
European-Non Finnish (NFE)
AF:
0.587
AC:
39898
AN:
67962
Other (OTH)
AF:
0.625
AC:
1314
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1773
3545
5318
7090
8863
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
762
1524
2286
3048
3810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.591
Hom.:
106946
Bravo
AF:
0.633
TwinsUK
AF:
0.598
AC:
2217
ALSPAC
AF:
0.579
AC:
2232
ESP6500AA
AF:
0.793
AC:
3493
ESP6500EA
AF:
0.595
AC:
5121
ExAC
AF:
0.552
AC:
67071
Asia WGS
AF:
0.506
AC:
1760
AN:
3478
EpiCase
AF:
0.590
EpiControl
AF:
0.588

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jul 03, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 25, 2013
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:3
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Seckel syndrome 1 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.059
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
10
DANN
Benign
0.59
DEOGEN2
Benign
0.046
T
Eigen
Benign
-0.76
Eigen_PC
Benign
-0.53
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.037
T
MetaRNN
Benign
8.8e-7
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
0.14
N
PhyloP100
1.5
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.20
N
REVEL
Benign
0.089
Sift
Benign
1.0
T
Sift4G
Benign
0.92
T
Polyphen
0.0
B
Vest4
0.023
MPC
0.18
ClinPred
0.0013
T
GERP RS
4.6
Varity_R
0.081
gMVP
0.20
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2227928; hg19: chr3-142281612; COSMIC: COSV63383325; COSMIC: COSV63383325; API